{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:20:45Z","timestamp":1788272445654,"version":"build-2803163510"},"reference-count":49,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Liver cirrhosis (LC) is a progressive disease characterised by chronic liver inflammation, leading to diminished liver function and complex symptomatology. As LC advances to decompensated cirrhosis and end-stage liver disease (ESLD), patients experience severe symptoms such as pain, ascites and encephalopathy, significantly impairing their quality of life. Despite the high symptom burden and a substantial mortality rate, palliative care remains grossly underused.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This review aims to explore the current state of palliative care utilization in ESLD patients, identify barriers to palliative care access, and discuss strategies for enhancing symptom management and improving patient quality of life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A comprehensive literature review was performed of palliative care in liver cirrhosis, symptom prevalence, management strategies, and barriers to palliative care consultation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and data sources<\/jats:title>\n                  <jats:p>Our review synthesized information from 49 referenced sources, covering symptom management, healthcare utilization, and palliative care approaches with regards to liver cirrhosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>We find significant underutilization of palliative care services, with consultation rates as low as 0.97% for patients with decompensated cirrhosis. Key barriers include liver transplant eligibility, racial disparities, and lack of insurance coverage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Despite evidence suggesting that palliative care improves patient outcomes and quality of life, its implementation in patients with ESLD remains insufficient. Increasing awareness and integration of palliative care into routine management for these patients are crucial. The concept of primary palliative care is proposed as a means to bridge the gap until specialised services are available, allowing all clinicians contribute to alleviating patient suffering and improving overall care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/spcare-2024-005247","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T16:47:48Z","timestamp":1752511668000},"page":"600-605","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Palliative care in cirrhosis of the liver"],"prefix":"10.1136","volume":"15","author":[{"given":"Feras","family":"Al-Moussally","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida, USA"},{"name":"University of Central Florida HCA Florida Healthcare, Greater Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Tejada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida, USA"},{"name":"University of Central Florida HCA Florida Healthcare, Greater Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0022-750X","authenticated-orcid":false,"given":"Saud","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida, USA"},{"name":"University of Central Florida HCA Florida Healthcare, Greater Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Mandalia","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, Orlando VA Healthcare System, Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabiha","family":"Kazi","sequence":"additional","affiliation":[{"name":"Section of Hospice and Palliative Care, Orlando VA Healthcare System, Orlando, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"2025082602150806000_15.5.600.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5997"},{"key":"2025082602150806000_15.5.600.2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.32378","article-title":"AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis","volume":"76","author":"Rogal","year":"2022","journal-title":"Hepatology"},{"key":"2025082602150806000_15.5.600.3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jpainsymman.2019.10.016","article-title":"Health Care Utilization and End-of-Life Care Outcomes for Patients With Decompensated Cirrhosis Based on Transplant Candidacy","volume":"59","author":"Ufere","year":"2020","journal-title":"J Pain Symptom Manage"},{"key":"2025082602150806000_15.5.600.4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cgh.2013.08.027","article-title":"Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management","volume":"12","author":"Poonja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025082602150806000_15.5.600.5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5604\/01.3001.0009.8594","article-title":"The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review","volume":"16","author":"Kelly","year":"2017","journal-title":"Ann Hepatol"},{"key":"2025082602150806000_15.5.600.6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/hep.29297","article-title":"Palliative care access for hospitalized patients with end-stage liver disease across the United States","volume":"66","author":"Rush","year":"2017","journal-title":"Hepatology"},{"key":"2025082602150806000_15.5.600.7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of Patients with Cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"N Engl J Med"},{"key":"2025082602150806000_15.5.600.8","doi-asserted-by":"publisher","DOI":"10.1177\/0269216318807051"},{"key":"2025082602150806000_15.5.600.9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025082602150806000_15.5.600.10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025082602150806000_15.5.600.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"2025082602150806000_15.5.600.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02716.x"},{"key":"2025082602150806000_15.5.600.13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.14309\/ajg.0000000000000545","article-title":"Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis","volume":"115","author":"Kok","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2025082602150806000_15.5.600.14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.pan.2022.05.007","article-title":"An ethical analysis of endoscopic therapy decision-making in patients with refractory substance use disorder and chronic pancreatitis","volume":"22","author":"Al-Moussally","year":"2022","journal-title":"Pancreatology"},{"key":"2025082602150806000_15.5.600.15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ajt.15276","article-title":"OPTN\/SRTR 2017 Annual Data Report: Liver","volume":"19","author":"Kim","year":"2019","journal-title":"Am J Transplant"},{"key":"2025082602150806000_15.5.600.16","unstructured":"When surrogates choose suffering a commentary. 2024. Available: https:\/\/www.researchsquare.com [Accessed 15 Feb 2024]."},{"key":"2025082602150806000_15.5.600.17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cld.711","article-title":"Pain management in patients with cirrhosis","volume":"11","author":"Rakoski","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2025082602150806000_15.5.600.18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/2049463714548768","article-title":"Pain services and palliative medicine - an integrated approach to pain management in the cancer patient","volume":"8","author":"O\u2019Brien","year":"2014","journal-title":"Br J Pain"},{"key":"2025082602150806000_15.5.600.19","unstructured":"Anekar AA , Hendrix JM , Cascella M . WHO analgesic ladder. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554435\/"},{"key":"2025082602150806000_15.5.600.20","unstructured":"McPherson ML . Demystifying Opioid Conversion Calculations. 2nd Ed. 2024."},{"key":"2025082602150806000_15.5.600.21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2478\/jtim-2020-0034","article-title":"Hepatic Encephalopathy: Diagnosis and Management","volume":"8","author":"Ridola","year":"2020","journal-title":"J Transl Int Med"},{"key":"2025082602150806000_15.5.600.22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cld.2020.01.006","article-title":"The Health Care Burden of Hepatic Encephalopathy","volume":"24","author":"Elsaid","year":"2020","journal-title":"Clin Liver Dis"},{"key":"2025082602150806000_15.5.600.23","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J Hepatol"},{"key":"2025082602150806000_15.5.600.24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/CEG.S160921","article-title":"A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans","volume":"11","author":"Levitt","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"key":"2025082602150806000_15.5.600.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.042"},{"key":"2025082602150806000_15.5.600.26","first-page":"5","article-title":"Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles","volume":"79","author":"Weissenborn","year":"2019","journal-title":"Drugs (Abingdon Engl)"},{"key":"2025082602150806000_15.5.600.27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13010166","article-title":"The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas","volume":"13","author":"Bellafante","year":"2023","journal-title":"J Clin Med"},{"key":"2025082602150806000_15.5.600.28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","author":"Montagnese","year":"2022","journal-title":"J Hepatol"},{"key":"2025082602150806000_15.5.600.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.02067.x"},{"key":"2025082602150806000_15.5.600.30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.30304","article-title":"Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"key":"2025082602150806000_15.5.600.31","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10620-013-3021-2","article-title":"Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience","volume":"59","author":"Lee","year":"2014","journal-title":"Dig Dis Sci"},{"key":"2025082602150806000_15.5.600.32","doi-asserted-by":"publisher","DOI":"10.1136\/jim-d-15-00181"},{"key":"2025082602150806000_15.5.600.33","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S136578"},{"key":"2025082602150806000_15.5.600.34","unstructured":"Ranasinghe IR , Sharma B , Bashir K . Hepatorenal syndrome. In: StatPearls. StatPearls Publishing, 2024. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430856\/"},{"key":"2025082602150806000_15.5.600.35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31884"},{"key":"2025082602150806000_15.5.600.36","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.176495"},{"key":"2025082602150806000_15.5.600.37","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i10.2704"},{"key":"2025082602150806000_15.5.600.38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321790"},{"key":"2025082602150806000_15.5.600.39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjms.2023.10.006","article-title":"Early palliative care referral may improve end-of-life care in end-stage liver disease patients: A retrospective analysis from a non-transplant center","volume":"367","author":"Shehadah","year":"2024","journal-title":"Am J Med Sci"},{"key":"2025082602150806000_15.5.600.40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2020.11.027","article-title":"AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review","volume":"19","author":"Tandon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025082602150806000_15.5.600.41","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1089\/jpm.2018.0553","article-title":"Attitudes of Liver and Palliative Care Clinicians toward Specialist Palliative Care Consultation for Patients with End-Stage Liver Disease","volume":"22","author":"Esteban","year":"2019","journal-title":"J Palliat Med"},{"key":"2025082602150806000_15.5.600.42","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5500\/wjt.v6.i3.594","article-title":"Underutilization of palliative care services in the liver transplant population","volume":"6","author":"Kathpalia","year":"2016","journal-title":"World J Transplant"},{"key":"2025082602150806000_15.5.600.43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cgh.2017.07.007","article-title":"Place of Death and Hospice Utilization Among Patients Who Die From Cirrhosis in the United States","volume":"16","author":"Altaii","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025082602150806000_15.5.600.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2018.01.011"},{"key":"2025082602150806000_15.5.600.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1215620"},{"key":"2025082602150806000_15.5.600.46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.hrtlng.2022.07.002","article-title":"Primary palliative care for heart failure provided within ambulatory cardiology: A randomized pilot trial","volume":"56","author":"Kavalieratos","year":"2022","journal-title":"Heart Lung"},{"key":"2025082602150806000_15.5.600.47","doi-asserted-by":"crossref","DOI":"10.1186\/s12904-021-00783-6","article-title":"Can primary palliative care education change life-sustaining treatment intensity of older adults at the end of life? A retrospective study","volume":"20","author":"Liu","year":"2021","journal-title":"BMC Palliat Care"},{"key":"2025082602150806000_15.5.600.48","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3182a76b9c"},{"key":"2025082602150806000_15.5.600.49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10741-017-9604-9","article-title":"Primary palliative care for heart failure: what is it? How do we implement it?","volume":"22","author":"Gelfman","year":"2017","journal-title":"Heart Fail Rev"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2024-005247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:16:02Z","timestamp":1756199762000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2024-005247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,8,26]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/spcare-2024-005247"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2024-005247","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}